Tarsus Pharmaceuticals, Inc.
TARS나스닥Biological Products, (No Diagnostic Substances)US미국
30일 공시 수
1건
최근 2026.10.14
90일 내부자 순매수
-48억 9,184만원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 10건
- US미국주요사항·수시공시중요도 낮음2026.10.14정정8-K/A · Current report (Items 9.01)
Tarsus Pharmaceuticals, Inc.TARS
8-K/A · 2026.10.14 05:00 KST
- US미국임원·주요주주 소유중요도 높음2026.09.174 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.17
- US미국임원·주요주주 소유중요도 낮음2026.09.174 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.17
- US미국임원·주요주주 소유중요도 낮음2026.09.174 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.17
- US미국합병·분할·인수중요도 높음2026.09.118-K · Current report (Items 2.01, 8.01, 9.01)
Tarsus Pharmaceuticals, Inc.TARS
8-K · 2026.09.11 05:05 KST
- US미국임원·주요주주 소유중요도 높음2026.09.094 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.09
- US미국임원·주요주주 소유중요도 높음2026.09.094 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.09
- US미국임원·주요주주 소유중요도 보통2026.09.094 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.09
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Tarsus Pharmaceuticals, Inc.TARS
Form 4 · 2026.09.03